[Federal Register: March 27, 2003 (Volume 68, Number 59)] [Notices] [Page 14967] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr27mr03-30] ----------------------------------------------------------------------- DEPARTMENT OF DEFENSE Department of the Navy Notice of Intent To Grant Exclusive Patent License; American BioHealth Group, LLC AGENCY: Department of the Navy, DOD ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Department of the Navy hereby gives notice of its intent to grant to American BioHealth Group, LLC, a revocable, nonassignable, exclusive license in the United States to practice, with right to sublicense, the Government-owned invention described in U.S. Patent Application Serial No. 09/766, 625, entitled ``Prevention or Reversal of Sensorial Hearing Loss Through Biological Mechanisms,'' filed January 23, 2001. DATES: Anyone wishing to object to the granting of this license has (15) days from the date of this notice to file written objections along with supporting evidence, if any. ADDRESSES: Written objections are to be filed with the Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave, Silver Spring, MD 20910-7500. FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave, Silver Spring, MD 20910-7500, telephone (301) 319-7428, fax (301) 319-7432, or E-Mail: schlagelc@nmrc.navy.mil. Dated: March 14, 2003. R. E. Vincent II, Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, Federal Register Liaison Officer. [FR Doc. 03-7351 Filed 3-26-03; 8:45 am]